Health Care News and Research

RSS

Safety and immunogenicity clinical trial of Ebola vaccine regimen starts in Sierra Leone

Johnson & Johnson today announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pharmaceutical Companies.

9 Oct 2015

FDA approves expanded indication for Optune device for brain cancer patients

The U.S. Food and Drug Administration today approved an expanded indication for the Optune device to treat patients with newly-diagnosed glioblastoma multiforme (GBM), an aggressive form of brain cancer.

9 Oct 2015

Hi-Tech Pharmaceuticals signs definitive agreement to acquire iForce

Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition products, Contract Manufacturing, and iForce Nutrition ("iForce"), one of the fastest-growing Sports Nutrition companies in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire iForce.

9 Oct 2015

Leading experts to discuss role of laboratory medicine in personalized medicine

Join the American Association for Clinical Chemistry (AACC) and leading experts in laboratory medicine and diagnostic testing for a discussion of how laboratory medicine is driving the future of personalized medicine and the policies to support these new technologies.

9 Oct 2015

Pitt research team awarded NIH grant to study impact of substance abuse on adolescent brain development

A research team in the department of psychiatry, at the University of Pittsburgh, has been awarded a $5 Million National Institutes of Health grant to participate in a multi-site study focusing on the impact of adolescent marijuana, alcohol and other drug use on the developing brain.

9 Oct 2015

Aristada (aripiprazole lauroxil) extended release injection approved to treat adults with schizophrenia

On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.

9 Oct 2015

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.

9 Oct 2015

Brain & Behavior Research Foundation to honor nine scientists with Outstanding Achievement Prizes

The Brain & Behavior Research Foundation will honor nine scientists with its 2015 Outstanding Achievement Prizes for their work in schizophrenia, mood disorders, child and adolescent psychiatry, and cognitive neuroscience.

9 Oct 2015

New study examines factors that may protect transgender individuals from attempting suicide

The likelihood of a transgender person attempting suicide is very high, often because of the prejudice, transphobia and other stressors he or she may experience. A new study examined factors that may protect transgender adults from attempting suicide. Its conclusions also inform medical and mental health professionals who work with transgender clients.

9 Oct 2015

$Anti-osteoporotic therapy can decrease subsequent fracture risks by 40%: Study$

Anti-osteoporotic therapy can decrease subsequent fracture risks by 40%: Study

Osteoporosis, a disease of progressive bone loss, affects 70 percent of the U.S. population older than age 50: one in two women--and one in five men. These individuals are at risk for fragility fractures, a break that results from a fall, or occurs in the absence of obvious trauma, and most commonly seen in the wrist, the upper arm, the hip, and the spine.

9 Oct 2015

JKTG Foundation announces over $160K in awards to support next generation of health policy research

Today, the Jayne Koskinas Ted Giovanis Foundation announced over $160K in awards to support the next generation of health policy research and promote better healthcare for patients. Four graduate researchers in the field of health policy and administration at Brown University, Georgetown University, Harvard University and The Johns Hopkins University received Dissertation Support Grants (DSGs) to aid their research.

8 Oct 2015

Poll: Americans across political spectrum support presidential debate on science-based challenges

An overwhelming majority of Americans (87%) say it is important that candidates for President and Congress have a basic understanding of the science informing public policy issues, including majorities across the political spectrum (92% of Democrats, 90% of Republicans and 79% of Independents).

8 Oct 2015

Limiting consumption of sugary drinks helps combat childhood and adolescent obesity

More than one-third of children in the United States ages 6 to 19 years old are overweight or obese. Over the past 30 years, the number of obese adolescents has more than quadrupled, which also has led to an increase in children diagnosed with diabetes. To combat this trend, Aneesh Tosh, M.D., adolescent medicine physician at University of Missouri Health Care and associate professor of clinical child health at the MU School of Medicine, recommends that sugary drinks be removed from adolescents' diets.

8 Oct 2015

New book suggests ways to reduce medical reversals

Medical reversal—when accepted medical interventions are abandoned because they are found to be ineffective—is the "most important problem in medicine today," according to the authors of a new book: Ending Medical Reversal.

8 Oct 2015

Half-matched donor bone marrow transplant just as good as full match, new study shows

Bone marrow transplantation is a life-saving therapy for many patients with blood cancers like leukemias and lymphomas. Currently, the gold standard blood-generating stem cells are obtained from a donor, a sibling, with a perfect match to the patient in order to minimize the chance of rejection and other complications. However, not all patients will have a perfectly matched sibling. Some cancer centers have begun to explore whether half-matched donors might work just as well.

8 Oct 2015

Dan's House of Hope selected to receive ASTRO's 2015 Survivor Circle grant

The American Society for Radiation Oncology has selected a Houston-based cancer patient support group, Dan's House of Hope, to receive ASTRO's 2015 Survivor Circle grant. The organization will receive $8,500 to recognize its efforts and provide direct support for the organization's work assisting cancer patients and their families.

8 Oct 2015

Endocrine Society issues Clinical Practice Guideline on treatment of menopausal symptoms

The Endocrine Society today issued a Clinical Practice Guideline (CPG) on identifying women who are candidates for treatment of menopausal symptoms and selecting the best treatment options for each individual.

8 Oct 2015

Closure of women's health clinics due to government cuts affects preventive care

When women's health clinics close because of government funding cuts aimed at abortion providers, fewer women seek lifesaving preventive care that can identify health threats such as cancer, research from the University of Kansas shows.

8 Oct 2015

Skin cancer rates higher among gay and bisexual men, UCSF-led study finds

Gay and bisexual men were up to six times more likely than heterosexual men to take part in indoor tanning, and twice as likely to report a history of skin cancer, including nonmelanoma and melanoma, according to a study led by UC San Francisco researchers.

8 Oct 2015

Advanced pneumatic compression device reduces cellulitis episodes, saves money for lymphedema patients

Lymphedema patients saw a nearly 80 percent reduction in their cellulitis episodes just by using an advanced pneumatic compression device at home, according to a study in JAMA Dermatology co-authored by Vanderbilt University School of Nursing Professor Sheila Ridner, PhD, MSHSA, FAAN, and University of Minnesota School of Public Health Associate Professor Pinar Karaca-Mandic, PhD.

8 Oct 2015

Health Care News and Research

Safety and immunogenicity clinical trial of Ebola vaccine regimen starts in Sierra Leone

FDA approves expanded indication for Optune device for brain cancer patients

Hi-Tech Pharmaceuticals signs definitive agreement to acquire iForce

Leading experts to discuss role of laboratory medicine in personalized medicine

Pitt research team awarded NIH grant to study impact of substance abuse on adolescent brain development

Aristada (aripiprazole lauroxil) extended release injection approved to treat adults with schizophrenia

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

Brain & Behavior Research Foundation to honor nine scientists with Outstanding Achievement Prizes

New study examines factors that may protect transgender individuals from attempting suicide

Anti-osteoporotic therapy can decrease subsequent fracture risks by 40%: Study

JKTG Foundation announces over $160K in awards to support next generation of health policy research

Poll: Americans across political spectrum support presidential debate on science-based challenges

Limiting consumption of sugary drinks helps combat childhood and adolescent obesity

New book suggests ways to reduce medical reversals

Half-matched donor bone marrow transplant just as good as full match, new study shows

Dan's House of Hope selected to receive ASTRO's 2015 Survivor Circle grant

Endocrine Society issues Clinical Practice Guideline on treatment of menopausal symptoms

Closure of women's health clinics due to government cuts affects preventive care

Skin cancer rates higher among gay and bisexual men, UCSF-led study finds

Advanced pneumatic compression device reduces cellulitis episodes, saves money for lymphedema patients

Event guide: 3rd Measuring Patient Engagement Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News